Home › PsiOxus Therapeutics to Release Study Results of Oncolytic Vaccine Enadenotucirev in Cancer Patients
 

Keywords :   


PsiOxus Therapeutics to Release Study Results of Oncolytic Vaccine Enadenotucirev in Cancer Patients

2014-05-21 18:54:23| Logistics - Topix.net

The EVOLVE trial is a phase I/II trial of intravenous administration of enadenotucirev to patients with epithelial cancers and the MoA trial is a phase I "window of opportunity" trial evaluating intravenous and intra-tumoural administration of enadenotucirev to patients with colon cancer.

Tags: results study release cancer

Category:Transportation and Logistics

Latest from this category

All news
01.07Hurricane Beryl Forecast Discussion Number 11
01.07Hurricane Beryl Graphics
01.07Hurricane Beryl Wind Speed Probabilities Number 11
01.07Summary for Hurricane Beryl (AT2/AL022024)
01.07Hurricane Beryl Public Advisory Number 11
01.07Hurricane Beryl Forecast Advisory Number 11
01.07Tropical Storm Chris Forecast Discussion Number 3
01.07Tropical Storm Chris Wind Speed Probabilities Number 3
Transportation and Logistics »
01.07Union expected to call off Port Talbot strike action
01.07Mentorship in Motion
01.07Farm Progress America, July 1, 2024
01.07Hurricane Beryl Forecast Discussion Number 11
01.07Hurricane Beryl Graphics
01.07Hurricane Beryl Wind Speed Probabilities Number 11
01.07Hurricane Beryl Forecast Advisory Number 11
01.07Hurricane Beryl Public Advisory Number 11
More »